Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Department of Arthroplasty, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Cell Death Differ. 2018 Sep;25(9):1549-1566. doi: 10.1038/s41418-017-0049-4. Epub 2018 Jan 22.
Reorganization of the podosome into the sealing zone is crucial for osteoclasts (OCLs) to resorb bone, but the underlying mechanisms are unclear. Here, we show that tuberous sclerosis complex 1 (TSC1) functions centrally in OCLs to promote podosome organization and bone resorption through mechanistic target of rapamycin complex 1 (mTORC1) and the small GTPases Rac1/Cdc42. During osteoclastogenesis, enhanced expression of TSC1 downregulates mTORC1 activity. TSC1 deletion in OCLs reduced podosome belt formation in vitro and sealing zone formation in vivo, leading to bone resorption deficiency and osteopetrosis. Mechanistically, TSC1 promoted podosome superstructure assembly by releasing mTORC1-dependent negative feedback inhibition of Rac1/Cdc42. Rapamycin and active Rac1/Cdc42 restore podosome organization and bone resorption and alleviate osteopetrotic phenotypes in mutant mice. Our findings reveal an essential role of TSC1 signaling in the regulation of bone resorption. Targeting TSC1 represents a novel strategy to inhibit bone resorption and prevent bone loss-related diseases.
破骨细胞(OCLs)重吸收骨骼的过程中,须将足突重新整合成封闭区,这一过程对破骨细胞功能至关重要,但其中的具体机制尚不清楚。本研究表明,结节性硬化复合物 1(TSC1)在破骨细胞中发挥核心作用,通过雷帕霉素靶蛋白复合物 1(mTORC1)和小 GTP 酶 Rac1/Cdc42 促进破骨细胞足突的形成和骨吸收。在破骨细胞分化过程中,TSC1 的表达增强会降低 mTORC1 的活性。在破骨细胞中敲除 TSC1 会减少体外破骨细胞足突带的形成和体内封闭区的形成,导致骨吸收缺陷和骨质增生。其作用机制为,TSC1 通过释放 mTORC1 依赖性负反馈抑制 Rac1/Cdc42,促进了足突超微结构的组装。雷帕霉素和活性 Rac1/Cdc42 恢复了破骨细胞的足突形成和骨吸收,并减轻了突变小鼠的骨质增生表型。这些发现揭示了 TSC1 信号在骨吸收调控中的重要作用。靶向 TSC1 可能成为抑制骨吸收和预防与骨丢失相关疾病的一种新策略。